van Twuyver E[au] - Search Results

Year	Number of Results
1988	1
1989	2
1990	2
1991	4
1992	1
1993	1
1994	2
1995	1
1996	2
1998	1
2011	1
2012	1
2022	0

1

Pretransplantation blood transfusion revisited.

van Twuyver E, Mooijaart RJ, ten Berge IJ, van der Horst AR, Wilmink JM, Kast WM, Melief CJ, de Waal LP. van Twuyver E, et al. N Engl J Med. 1991 Oct 24;325(17):1210-3. doi: 10.1056/NEJM199110243251704. N Engl J Med. 1991. PMID: 1922208 Free article.

2

Blood transfusion and allograft survival: is mixed chimerism the solution for tolerance induction in clinical transplantation?

de Waal LP, van Twuyver E. de Waal LP, et al. Among authors: van twuyver e. Crit Rev Immunol. 1991;10(5):417-25. Crit Rev Immunol. 1991. PMID: 2021424 Review. No abstract available.

3

Treatment of hereditary angioedema with nanofiltered C1-esterase inhibitor concentrate (Cetor®): multi-center phase II and III studies to assess pharmacokinetics, clinical efficacy and safety.

Hofstra JJ, Kleine Budde I, van Twuyver E, Choi G, Levi M, Leebeek FW, de Monchy JG, Ypma PF, Keizer RJ, Huitema AD, Strengers PF. Hofstra JJ, et al. Among authors: van twuyver e. Clin Immunol. 2012 Mar;142(3):280-90. doi: 10.1016/j.clim.2011.11.005. Epub 2011 Nov 16. Clin Immunol. 2012. PMID: 22197071 Clinical Trial.

4

Comparison of T cell responses in patients with a long-term surviving renal allograft versus a long-term surviving liver allograft. It's a different world.

van Twuyver E, de Hoop J, ten Berge RJ, Wilmink JM, Lems SP, van de Berg AP, Slooff MJ, de Waal LP. van Twuyver E, et al. Transplantation. 1996 May 15;61(9):1392-7. doi: 10.1097/00007890-199605150-00019. Transplantation. 1996. PMID: 8629303

5

Donor-specific immunological non-responsiveness after liver transplantation.

van den Berg AP, de Haan A, Hepkema BG, van Dijk E, van Twuyver E, Klompmaker IJ, de Leij LH, de Waal LP, Slooff MJ, The TH. van den Berg AP, et al. Among authors: van twuyver e. Transpl Int. 1998;11 Suppl 1:S239-41. doi: 10.1007/s001470050468. Transpl Int. 1998. PMID: 9664986

6

Frequency analysis of HLA-specific cytotoxic T lymphocyte precursors in humans.

Breur-Vriesendorp BS, Vingerhoed J, van Twuyver E, de Waal LP, Ivanyi P. Breur-Vriesendorp BS, et al. Among authors: van twuyver e. Transplantation. 1991 May;51(5):1096-103. doi: 10.1097/00007890-199105000-00032. Transplantation. 1991. PMID: 2031263

7

cis-acting regulatory elements abrogate allele-specific HLA class I gene expression in healthy individuals.

Lardy NM, Bakas RM, van der Horst AR, van Twuyver E, Bontrop RE, de Waal LP. Lardy NM, et al. Among authors: van twuyver e. J Immunol. 1992 Apr 15;148(8):2572-7. J Immunol. 1992. PMID: 1560211

8

Mechanism of skin allograft enhancement across an H-2 class I mutant difference. Evidence for involvement of veto cells.

Kast WM, Van Twuyver E, Mooijaart RJ, Verveld M, Kamphuis AG, Melief CJ, De Waal LP. Kast WM, et al. Among authors: van twuyver e. Eur J Immunol. 1988 Dec;18(12):2105-8. doi: 10.1002/eji.1830181238. Eur J Immunol. 1988. PMID: 2975604

9

Induction of transplantation tolerance by intravenous injection of allogeneic lymphocytes across an H-2 class II mismatch. Different mechanisms operate in tolerization across an H-2 class I vs. H-2 class II disparity.

van Twuyver E, Kast WM, Mooijaart RJ, Melief CJ, De Waal LP. van Twuyver E, et al. Eur J Immunol. 1990 Feb;20(2):441-4. doi: 10.1002/eji.1830200232. Eur J Immunol. 1990. PMID: 2311650

10

Anti-CD3 treatment facilitates engraftment of full H-2-disparate donor bone marrow cells and subsequent skin allograft tolerance.

de Vries-van Der Zwan A, Besseling AC, Kievits F, van Twuyver E, de Waal LP. de Vries-van Der Zwan A, et al. Among authors: van twuyver e. Transplantation. 1994 Sep 15;58(5):610-7. doi: 10.1097/00007890-199409150-00014. Transplantation. 1994. PMID: 7522366

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results